Clinical Trial Update: Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women [Phase 3]

View source ↗

Summary

Phase 3 study evaluating a bazedoxifene/conjugated estrogens combination in postmenopausal women has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Hyperplasia
• Osteoporosis

Drugs mentioned

• Bazedoxifene (bazedoxifene)
• Conjugated Estrogens (ESTROGENS, CONJUGATED)
• Duavee (bazedoxifene/conjugated estrogens)

Snippet

Sponsor: Pfizer | Conditions: Endometrial Hyperplasia, Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2013-12-20